A new trading day began on Friday, with ProKidney Corp (NASDAQ: PROK) stock price up 3.63% from the previous day of trading, before settling in for the closing price of $1.93. PROK’s price has ranged from $1.12 to $4.44 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 12.21%. With a float of $75.82 million, this company’s outstanding shares have now reached $126.05 million.
Let’s look at the performance matrix of the company that is accounted for 163 employees. In terms of profitability, gross margin is 17.94%, operating margin of -3058.21%, and the pretax margin is -2976.59%.
ProKidney Corp (PROK) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of ProKidney Corp is 39.85%, while institutional ownership is 38.77%. The most recent insider transaction that took place on Sep 19 ’24, was worth 41,030. In this transaction Chief Regulatory Officer of this company sold 16,412 shares at a rate of $2.50, taking the stock ownership to the 103,480 shares. Before that another transaction happened on Sep 19 ’24, when Company’s Officer proposed sale 16,412 for $2.39, making the entire transaction worth $39,225.
ProKidney Corp (PROK) Latest Financial update
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.18 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.21% per share during the next fiscal year.
ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators
Here are ProKidney Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 21.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.59, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of ProKidney Corp (PROK)
ProKidney Corp (NASDAQ: PROK) saw its 5-day average volume 0.67 million, a negative change from its year-to-date volume of 0.72 million. As of the previous 9 days, the stock’s Stochastic %D was 95.50%. Additionally, its Average True Range was 0.14.
During the past 100 days, ProKidney Corp’s (PROK) raw stochastic average was set at 41.04%, which indicates a significant decrease from 94.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.98% in the past 14 days, which was lower than the 92.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.97, while its 200-day Moving Average is $2.15. Nevertheless, the first resistance level for the watch stands at $2.06 in the near term. At $2.11, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.20. If the price goes on to break the first support level at $1.92, it is likely to go to the next support level at $1.83. The third support level lies at $1.78 if the price breaches the second support level.
ProKidney Corp (NASDAQ: PROK) Key Stats
With a market capitalization of 600.36 million, the company has a total of 289,675K Shares Outstanding. Currently, annual sales are 0 K while annual income is -35,470 K. The company’s previous quarter sales were 0 K while its latest quarter income was -12,510 K.
